Using single-cell genomic sequencing, researchers identified somatic genetic mutations in the brains of CTE, RHI, and AD individuals.

Novo Nordisk has made an unsolicited, approximately up to $9 billion bid for Metsera—more than a month after Pfizer announced its intent to buy the company for up to $7.3 billion.

One of several findings was the discovery of a group of cells, likely unique to humans, that may help the heart respond to low oxygen levels.